Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]
Phase 1 trial assessing infectivity, safety, and immunogenicity of a recombinant live-attenuated RSV vaccine in seronegative infants; study …
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study [Phase 2]
This Phase 2 RSV viral challenge trial update reports safety, efficacy and pharmacokinetics data for BTA-C585.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety Study of Oral BTA9881 to Treat RSV Infection [Phase 1]
Phase 1 safety study of oral BTA9881 for Respiratory syncytial virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
Phase 2 trial updates on presatovir for hospitalized adults with RSV infection, focusing on efficacy, pharmacokinetics, and safety after stu…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract [Phase 2]
Phase 2 clinical trial update for Presatovir in hematopoietic cell transplant recipients with lower respiratory tract RSV infection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
This completed trial update reports how RSV monoclonal antibody therapy was used and how compliant sites were with its administration for RS…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus [Phase 3]
Phase 3 study evaluating the safety and effectiveness of palivizumab in high-risk children for RSV infection in Russia and Belarus; the tria…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults [Phase 1]
Phase 1 study evaluating the safety and immunogenicity of MEDI7510 in older adults with respiratory syncytial virus infection; results have …
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176 [Phase 1]
This update reports the completion of a Phase 1 open-label study evaluating the absorption, metabolism, excretion, and absolute bioavailabil…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating single and multiple doses of the RSV antiviral ALS-008176 in…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women [Phase 2]
Phase 2 safety, reactogenicity and immunogenicity study of different formulations of GSK's investigational RSV vaccine (GSK3003891A) in heal…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) [Phase 1]
A Phase 1 intranasal challenge trial of respiratory syncytial virus in healthy adults sponsored by MedImmune was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women [Phase 2]
Phase 2 safety and reactogenicity results for GSK's investigational RSV vaccine (GSK3003891A) in healthy women have been completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Effect of Heliox on RSV Bronchiolitis [Phase 3]
A Phase 3 trial assessing the effect of heliox on respiratory syncytial virus bronchiolitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating the safety, reactogenicity and immunogenicity of GlaxoSmithK…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression [Phase 1]
A Phase 1 trial from GlaxoSmithKline evaluated Danirixin (GSK1325756) for its ability to inhibit CD11b cell surface expression in the settin…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Specific Respiratory Infections as Triggers of Acute Medical Events
A completed clinical trial update examining whether specific respiratory infections act as triggers for acute medical events, including card…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®
Clinical trial update for Synagis Liquid 50mg and 100mg for intramuscular injection in immunocompromised children with Respiratory Syncytial…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [Phase 1]
Phase 1 trial update reporting safety and immune response data for a live-attenuated Respiratory Syncytial Virus vaccine in RSV-seronegative…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Idylla IFV-RSV Panel Clinical Testing
Clinical trial NCT02786381 assessing the Idylla IFV-RSV Panel for detecting influenza and RSV completed testing with Janssen as sponsor.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers [Phase 1]
This Phase 1 trial evaluated the safety, tolerability and immunogenicity of two RSV vaccine candidates, Ad26.RSV.FA2 followed by Ad35.RSV.FA…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults [Phase 1]
Phase 1 study evaluating the safety of the RSV vaccine MEDI7510 in older adults has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections
A Janssen-sponsored clinical trial in Belgian children hospitalized with RSV-related acute respiratory infections has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [Phase 1]
Phase 1 clinical trial assessing the safety and immune response of a single-dose Respiratory Syncytial Virus vaccine in RSV-seronegative inf…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis
Observational program evaluating hospitalization rates for respiratory syncytial virus in high-risk children who received palivizumab prophy…